University Of Sydney is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| | |
|---|---|
| **Name** | University of Sydney |
| **Location** | Sydney, New South Wales, Australia |
| **Type** | Public Research University |
| **Founded** | 1850 |
| **Website** | [sydney.edu.au](https://sydney.edu.au) |
| **Rankings** | Top 30 globally |
The University of Sydney (USYD) is Australia's first university, established in 1850. Located in Sydney, New South Wales, it is one of the world's leading research universities with particular strength in medicine, health sciences, and neuroscience. The university has been at the forefront of neurodegenerative disease research in the Asia-Pacific region.
¶ Brain and Mind Centre
The University of Sydney's Brain and Mind Centre is a multidisciplinary hub for neuroscience and neurological disease research:
- Centre for Parkinson's Disease: Comprehensive research on PD diagnosis, treatment, and biomarkers
- Dementia Research Centre: Focus on Alzheimer's disease and related dementias
- Motor Neuron Disease Research: ALS and frontotemporal dementia research program
- Multiple Sclerosis Research: Neuroimmunology and demyelination studies
| Disease Area |
Research Focus |
Key Labs/Groups |
| Parkinson's Disease |
Alpha-synuclein, LRRK2, gait analysis |
Prof. Simon J. G. Lewis |
| Alzheimer's Disease |
Biomarkers, neuroimaging, clinical trials |
Prof. Dr. Karen L. M. S. |
| ALS |
Genetic factors, biomarkers |
Prof. Matthew C. Kiernan |
| Multiple Sclerosis |
Neuroprotection, remyelination |
Prof. Michael H. Barnett |
| Huntington's Disease |
Genetic therapies, biomarker development |
Prof. Clement J. L. Loy |
- Prof. Dr. Simon J. G. Lewis: Professor of Parkinson's Disease Research, expert in Parkinson's disease gait and balance disorders
- Prof. Dr. Matthew C. Kiernan: Leading authority on ALS, Editor-in-Chief Brain journal
- Prof. Dr. Michael H. Barnett: International expert in multiple sclerosis and neuroimmunology
- Prof. Dr. Ian P. Hickie: Psychiatrist and neuroscientist focusing on depression and brain disorders
The University of Sydney offers extensive training in neuroscience and neurodegeneration:
- Sydney Neuroscience Academy: Professional development for clinicians and researchers
- PhD Program in Neuroscience: Comprehensive training through the Brain and Mind Centre
- Medical Research Training Scheme: Clinician-scientist training in neurodegeneration
¶ Major Discoveries and Contributions
- Parkinson's Disease Progression Markers: Development of novel biomarkers for PD progression
- ALS Genetic Studies: Identification of new genetic risk factors for ALS
- Multiple Sclerosis Treatments: Clinical trials for novel neuroprotective therapies
- Dementia Care Models: Development of integrated care models for dementia patients
USYD maintains active collaborations with:
- Macquarie University (Australia)
- University of Melbourne
- King's College London
- University College London
- US institutions (Harvard, Stanford)
- European research consortia
The study of University Of Sydney has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kiernan MC, et al. (2021). Amyotrophic lateral sclerosis. Lancet. PMID:33568215
- Lewis SJG, et al. (2020). Parkinson's disease: biomarkers and treatment. Nat Rev Neurol. PMID:32051652
- Barnett MH, et al. (2019). Multiple sclerosis: new horizons in therapy. Nat Rev Neurol. PMID:31118496